About | Team

Adrien Desjardins

Professor Adrien Desjardins – Chief Technical Officer

Adrien has a PhD from Harvard and the Massachusetts Institute of Technology (MIT). in Biomedical Engineering and Biophysics with a specific focus on cardiovascular devices, fibre optic sensing, and optical coherence tomography. After his PhD, he led technical developments in an internal venture at Philips Research (Netherlands) to develop devices with integrated optical sensors and brought this technology from benchtop prototypes to in vivo human studies. In addition to his responsibilities at Echopoint Medical, he is a Full Professor at UCL where he leads the interventional devices group with a vision to develop novel methods for performing physiological measurements and imaging with minimally invasive devices. He has over 52 patent applications and granted patents.

Malcolm Finlay

Dr Malcolm Finlay – Chief Medical Officer

Dr Malcolm Finlay is a Consultant Electrophysiologist and Honorary Senior Lecturer at Barts Heart Centre & UCL, London, specialising in minimally invasive treatments for heart disease. In addition to Echopoint, he has invented several medical technologies, including Epicardio Ltd. (4D heart simulation) and STAR Mapping (Rhythm AI Ltd) to aid treatment of atrial fibrillation. Dr. Finlay qualified from Oxford University in 2001, and gained his PhD in Cardiac Electrophysiology in 2014 from UCL, where he held a Wellcome Trust Research Training Fellowship. His work in technological innovation has been recognised by his appointment to the European Heart Rhythm Association Innovations Committee, he is a faculty member for several national and international academic conferences including Heart Rhythm Congress and the European Heart Rhythm Association. Outside of cardiology,
his interests include aviation (holding a private pilot’s license), filmmaking (check out “the last trip” from straight8.net), music and sports.

Marcus Gould

Marcus Gould – Regulatory & Quality Affairs

Throughout his career Marcus has worked for a number of start-up companies and established multi-national companies encompassing all aspects of CE mark, FDA, and global regulations. Marcus has obtained the CE mark for a wide range of medical device types and classifications, up to, and including, Class III systems, and has led, and obtained, IDE submissions within the US.

Marcus’s experience includes both pre-market and post-market activities, and he devises and implements regulatory strategies for CE Marking, US FDA submissions and global registrations.

Marcus has designed, implemented and maintained Quality Management Systems for ISO 9001, ISO 13485, and ISO 15189. Marcus holds a doctorate in biochemistry (microbiology) from the University of Oxford, holds both Chartered Biologist and Chartered Scientist status, and is a consultant editor for TOPRA’s monthly publication ‘Regulatory Rapporteur’.

Laura Lagonigro

Dr Richard Caulfield – Sensor Engineer

Dr Richard Caulfield graduated from Queen’s University Belfast with a MSci degree in Physics with Medical Applications (2015). During this time, he investigated the properties of atmospheric pressure non-thermal plasma jets and how they can be used to treat Biofilms. He then obtained a MRes degree at University College London (2016) where he continued working and completed his PhD in medical imaging (2020). His research centred on utilising high-resolution 3D printing techniques to develop miniaturised fibre optic imaging and sensing probes for use in minimally invasive surgeries. He has also worked on miniature imaging phantoms and all optical ultrasound imaging.

Outside of work, he enjoys exploring the multitude of pubs and restaurants on offer in London, watching and playing sports, as well as cooking and trying out new recipes in the kitchen

Laura Lagonigro

Chris Fenton – Data Scientist

After completing his master’s degree in Biomedical Engineering at Imperial College London, he started working at a medical technology startup in Hereford. There he worked as a data scientist and signal processing engineer within the R&D department, helping to develop cutting-edge medical technology. He has continued to work in a similar capacity at Echopoint.  Outside of work, he enjoys using his knowledge to develop electronics and software projects and is currently building an AI based stock trading bot. He also weight-lifts, skis, and plays guitar and drums, admittedly not very well.
Nijs Van der Vaart

Nijs Van der Vaart – Operations

Nijs has an extensive background in the medical device industry. He worked for Philips for more than 20 years in various management roles in Research & Development, Clinical Science & Medical Affairs, Strategic Customer Management and New Business Development, covering interventional cardiology, radiology, oncology and image-guided surgery. He headed the Innovation group in the interventional X-ray business, laying the foundation for a new generation cath labs with new clinical features and workflow concepts, in close collaboration with clinicians.  He headed an incubator to develop and launch breakthrough product concepts in the interventional imaging and physiology space. He brought several medical products to market all the way from initial embryonic lab idea to full market adoption and created new spin out companies with external investors. He recently started a new company and supports the med tech start-up community. Nijs is married and lives with four children in the Netherlands. He is designing and building his own zero-carbon family home at the waterfront and enjoys cooking, skiing, swimming and camping.

 Antony Odell

Antony Odell – Executive Chair

Antony has extensive experience of taking early stage start-ups to full commercial activity and has a career spanning both major multinationals (Johnson & Johnson, Fresenius and Howmedica (Stryker)) as well as a number of spin outs from the NHS (Tayflow Technologies) and universities (Tissue Regenix Group PLC). Most recently at Tissue Regenix he took the company from a two-person spin- out to an AIM-listed company with operations in the UK, Germany and the US. Whilst CEO the company was listed on AIM and completed its first acquisition in the US of CellRight in August 2017. Current assignments include Director of NorthInvest (not for profit Angel network), Director of Tandem Nano Ltd and Executive Chair of EML. Antony owns two miniature dachshunds (Lottie & Lupin) and is a keen if inept gardener. He bakes great sourdough and enjoys cooking Italian and Middle Eastern food.